Application Information

This drug has been submitted to the FDA under the reference 208147/001.

Names and composition

"DYANAVEL XR" is the commercial name of a drug composed of AMPHETAMINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
208147/001 DYANAVEL XR AMPHETAMINE SUSPENSION, EXTENDED RELEASE/ORAL EQ 2.5MG BASE per ML

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
204326/001 ADZENYS XR-ODT AMPHETAMINE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL EQ 3.1MG BASE
204326/002 ADZENYS XR-ODT AMPHETAMINE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL EQ 6.3MG BASE
204326/003 ADZENYS XR-ODT AMPHETAMINE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL EQ 9.4MG BASE
204326/004 ADZENYS XR-ODT AMPHETAMINE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL EQ 12.5MG BASE
204326/005 ADZENYS XR-ODT AMPHETAMINE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL EQ 15.7MG BASE
204326/006 ADZENYS XR-ODT AMPHETAMINE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL EQ 18.8MG BASE
208147/001 DYANAVEL XR AMPHETAMINE SUSPENSION, EXTENDED RELEASE/ORAL EQ 2.5MG BASE per ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved